Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Asset Sales
  • Biotech
  • Contracts
  • FDA
  • General
  • Health Care
  • News

Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone Autoinjector

By Vandana Singh
Today, 11:50 AM
Eton Pharmaceuticals Inc (NASDAQ:ETON) has acquired the U.S. and Canadian rights to Crossject’s Zeneo hydrocortisone needleless autoinjector. The product is under…

ETON

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

SpringWorks Therapeutics Reveals Updated Interim Mirdametinib Data In Rare Genetic Disorder

By Vandana Singh
Today, 11:50 AM
SpringWorks Therapeutics Inc (NASDAQ:SWTX) announced an update on the previously reported interim data from the first 20 adult patients enrolled in…

SWTX

Read More
3 minute read
  • Biotech
  • General

ChromaDex Highlights Research Findings From ChromaDex External Research Program

By Bill Haddad
Today, 11:50 AM
New preclinical research in mice finds nicotinamide riboside (NR) prevented loss of bone mass, reduced neuroinflammation, and reduced the negative effects of alcohol-induced inflammation ChromaDex Corp. (NASDAQ:CDXC)

CDXC

Read More
1 minute read
  • Biotech
  • General

SpringWorks Therapeutics Announces Initiation Of Phase 1/2 Clinical Trial Of Mirdametinib In Children And Young Adults With Low-Grade Glioma

By Bill Haddad
Today, 11:50 AM
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today reported the initiation of a

SWTX

Read More
2 minute read
  • Biotech
  • General

Epizyme Launches EZH2Now Testing Program With Quest Diagnostics For Relapsed Or Refractory Follicular Lymphoma Patients

By Bill Haddad
Today, 11:50 AM
EZH2Now Testing Program is first of its kind to offer national single gene testing for EZH2 Epizyme (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel

DGX

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News
  • Penny Stocks
  • Small Cap

United Therapeutics Announces FDA Acceptance Of Tyvaso DPI New Drug Application For Priority Review

By Bill Haddad
Today, 11:50 AM
United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S.

MNKD

Read More
1 minute read
  • Biotech
  • General
  • News
  • Retail Sales
  • Small Cap

Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner

By Rachit Vats
Today, 11:50 AM
Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol 

AZN

Read More
1 minute read
  • Biotech
  • General
  • News

Regeneron Antibody Treatment Cuts Risk Of Death In Some Critical COVID-19 Patients, Large-Scale Study Finds

By Madhukumar Warrier
Today, 11:50 AM
Regeneron Pharmaceutical Inc.’s (NASDAQ: REGN) COVID-19 monoclonal antibody cocktail reduced the risk of death by 20% in hospitalized COVID-19 patients who have not mounted their own antibody response, a large-scale study in the U.K. published on Wednesday found.

REGN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Eli Lilly To Test Injectable Migraine Med Against Biohaven’s Oral Nurtec In Head-To-Head Study

By Vandana Singh
Today, 11:50 AM
Eli Lilly And Co (NYSE:LLY) will conduct a head-to-head study comparing once-monthly injectable Emgality (galcanezumab-gnlm) with Biohaven Pharmaceutical Holding Co Ltd’s (NYSE:BHVN) Nurtec…

BHVN

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres

By Vandana Singh
Today, 11:50 AM
The FDA has approved Eton Pharmaceuticals Inc’s (NASDAQ:ETON) Rezipres (ephedrine hydrochloride injection) to treat clinically significant hypotension occurring in the setting…

ETON

Posts navigation

Previous 1 … 768 769 770 … 789 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service